Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Director | $45K | +$36K | +400% | Jun 5, 2024 |
ALGS | Aligos Therapeutics, Inc. | Chief Financial Officer | Sep 4, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|